Celebrating National DNA Day
In this short video, learn how plasmids are revolutionizing personalized medicine with its wide array of applications. This overview is a perfect introduction to share with the non-scientist and students!
EQT to acquire majority interest in Aldevron, the leading global supplier of plasmid DNA used in cell and gene therapies
• EQT to partner with founder and CEO Michael Chambers,
as well as TA Associates, to support Aldevron on its future growth journey
James Brown, Ph.D., presenting "Standardized Plasmids for Viral Vector Production" tech talk at American Society of Gene & Cell Therapy Annual Meeting
Representatives from Aldevron will attend the 22nd Annual Meeting for the American Society of Gene & Cell Therapy (ASGCT), April 29 - May 2, 2019, in Washington, D.C.